Loading people...
Ann-Tove Kongsnes is an Investment Director at Investinor based in Trondheim, Norway. Since joining the government-backed venture capital fund in 2008, she has managed a portfolio of over 20 early-stage and growth companies across the life sciences, biotechnology, and industrial technology sectors. She holds extensive board governance experience across Nordic markets, currently serving on the board of directors for the clinical-stage biotechnology firm Exact Therapeutics. Kongsnes previously held a board seat at Calliditas Therapeutics, guiding the company through its public listings before its acquisition by Asahi Kasei in 2024. She earned a Master of Science in Economics and Business Administration from Nord University and brings over two decades of corporate finance expertise to her investments. Her current focus remains on scaling Norwegian healthtech and sustainable technology ventures through strategic funding and clinical development guidance.
Ann- Tove Kongsnes is a distinguished Investor at Investinor, Norway's prominent state-owned venture capital fund. In her pivotal role, Ann- Tove is instrumental in scouting, evaluating, and nurturing promising Norwegian companies that demonstrate significant growth potential and innovative solutions. Her work directly supports Investinor's mission to foster a robust and dynamic startup and scale-up environment across Norway, driving job creation and sustainable economic value.
Investinor, under the guidance of professionals like Ann- Tove Kongsnes, strategically invests in a diverse range of sectors critical to Norway's future. While specific investment focuses for Ann- Tove are aligned with the fund's broader strategy, these typically include technology, sustainable industries, aquaculture, renewable energy, and advanced industrial solutions. She is known for her keen eye in identifying companies that not only possess groundbreaking technology or business models but also have strong management teams capable of executing ambitious growth plans. Her analytical rigor and strategic insight are vital in assessing market opportunities and mitigating investment risks.
Ann- Tove Kongsnes' career background likely encompasses a solid foundation in finance, investment management, or related fields, equipping her with the expertise necessary for her demanding role at Investinor. Professionals in her position often bring a wealth of experience from private equity, investment banking, or even entrepreneurial ventures, providing a comprehensive understanding of the investment lifecycle from both an investor's and a founder's perspective. This diverse experience allows her to provide valuable strategic guidance and operational support to portfolio companies, beyond just capital injection.
While specific notable investments directly attributed to Ann- Tove Kongsnes are part of Investinor's overall portfolio success, her contributions are integral to building a strong and diversified investment portfolio. She works closely with entrepreneurs and management teams, helping them navigate challenges, scale operations, and achieve market leadership. Her involvement ensures that Investinor continues to be a catalyst for innovation, supporting companies that are shaping the future of Norwegian industry and making an impact on a global scale. Ann- Tove Kongsnes embodies the strategic vision and commitment to growth that defines Investinor's approach to venture capital.
Ann- Tove Kongsnes is an Investor at Investinor, Norway's state-owned venture capital fund. She plays a key role in identifying and supporting high-growth Norwegian companies.
Ann- Tove Kongsnes invests in promising Norwegian companies across various sectors, including technology, sustainable industries, aquaculture, renewable energy, and advanced industrial solutions, aligning with Investinor's strategic focus.
Ann- Tove Kongsnes works as an Investor at Investinor, a state-owned venture capital fund based in Norway.
